2 completed, 2 recruiting, 1 not yet recruiting, 1 unknown. 5 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 5 | Completed 2, Not yet recruiting 1, Recruiting 1, Unknown 1 |
Follow Cagent Vascular LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Revascularization With Modification Using Definitive IVL and Serration Remodeling for Optimal Lumen Serranator Sonic Intravascular Lithotripsy (IVL) System - Peripheral Artery Disease | Not applicable | Not yet recruiting | Cagent Vascular LLC | 30 | 2026-05-01 | 2026-05-08 |
| Serranator POINT FORCE Registry Peripheral balloon angioplasty - Peripheral Artery Disease (PAD), Dysfunctional AV Fistula | Recruiting | Cagent Vascular LLC | 500 | 2025-01-22 | 2026-05-07 | |
| Serrantor OCT Study Serranator PTA Serration Catheter, PTA (Standard of Care) - Critical Limb Ischemia | Not applicable | Recruiting | Cagent Vascular LLC | 60 | 2024-10-31 | 2025-05-18 |
| Serranator Recoil Study Serranator, POBA - Peripheral Arterial Disease, Critical Limb Ischemia | Not applicable | Unknown | Cagent Vascular LLC | 20 | 2021-11-15 | 2022-06-09 |
| The PRELUDE BTK Study Serranator - Peripheral Arterial Disease, Critical Limb Ischemia | Not applicable | Completed | Cagent Vascular LLC | 49 | 2019-12-17 | 2021-01-28 |
| Serranator® Alto Post Market Clinical Follow Up (PMCF) Study Serranator® Alto - Peripheral Arterial Disease, Arterio-venous Fistula | Withdrawn | Cagent Vascular LLC | 2019-09-01 | 2020-04-10 | ||
| PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE Serranator™ Alto PTA Serration Balloon Catheter - Peripheral Arterial Disease | Not applicable | Completed | Cagent Vascular LLC | 25 | 2017-02-01 | 2018-04-24 |
Peripheral Arterial Disease (6) · Chronic Limb-Threatening Ischemia (3) · Arteriovenous Fistula (1)
Drug Delivery Systems (1) · Standard of Care (1)
United States (3) · Austria (2) · Germany (2) · New Zealand (2) · Poland (2)